NCT01558882 is a clinical trial of Essure in Sterilization, Tubal, sponsored by Centre Hospitalier Universitaire de Nīmes.

Who is sponsoring NCT01558882?

NCT01558882 is sponsored by Centre Hospitalier Universitaire de Nīmes.

What drugs are being tested in NCT01558882?

Interventions in NCT01558882: Essure.

What condition does NCT01558882 study?

NCT01558882 studies Sterilization, Tubal.

Is NCT01558882 still recruiting?

NCT01558882 is currently terminated. Last updated 19 June 2017.

Last reviewed 2017-06-19 · How we verify

NCT01558882

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Impact of Essure Tubal Sterilization Devices on the Endometrium

Terminated Last updated 19 June 2017

What this trial tests

trial testing Essure in Sterilization, Tubal in 2 participants. Terminated before completion.

Timeline

21 January 2014

Primary endpoint
28 November 2014

28 November 2014

Quick facts

Lead sponsor	Centre Hospitalier Universitaire de Nīmes
Status	Terminated
Study type	OBSERVATIONAL
Enrollment	2
Start date	21 January 2014
Primary completion	28 November 2014
Estimated completion	28 November 2014
Sites	4 locations across France

Drugs / interventions tested

Essure

Conditions studied

Sterilization, Tubal — all drugs for Sterilization, Tubal →

Sponsor

Centre Hospitalier Universitaire de Nīmes

Who can join

35 and older, female only, with Sterilization, Tubal. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The mobilization of natural killer cells (uNK) triggers and coordinates all stages of embryo implantation. They are at the origin of the local secretion of cytokines, growth factors, chemokines affecting vascular development and the local immunotrophisme for the conceptus. The main objective of this study is to evaluate the expression of endometrial uNK cells before and after tubal obstruction by Essure devices. Endoluminal and endometrial levels of various cytokines and growth factors will also be studied.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Essure

Trials testing the same drug.

NCT03438682 — Real World Effectiveness and Safety of Hysteroscopic (Essure®) Compared to Laparoscopic Sterilization · completed

Other Centre Hospitalier Universitaire de Nīmes trials

Trials by the same sponsor.

NCT07403474 — Combined Use of a Respiratory Multiplex PCR and Algorithm-based Therapy to Improve Early Optimization of Antibiotic Ther · Phase 4 · not yet recruiting
NCT07455981 — Work Organization and Gambling Addiction · not yet recruiting
NCT07403500 — Evaluation of the Short-term Effectiveness of Spinal Manipulation to Treat Acute and Subacute Low Back Pain. · NA · not yet recruiting
NCT07342010 — Bicarbonate Addition to Lidocaine-Epinephrine in Surgery Under WALANT · Phase 4 · not yet recruiting
NCT07305727 — A Radiomic MRI Predictive Model for Response to Concomitant Chemoradiotherapy in Locally Advanced Cervical Cancer · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01558882 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Universitaire de Nīmes
Last refreshed: 19 June 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01558882.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing